-
1
-
-
29844439240
-
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels
-
DOI 10.1124/pr.57.4.5
-
Catterall, W. A., Perez-Reyes, E., Snutch, T. P. & Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411-425 (2005) (Pubitemid 43036432)
-
(2005)
Pharmacological Reviews
, vol.57
, Issue.4
, pp. 411-425
-
-
Catterall, W.A.1
Perez-Reyes, E.2
Snutch, T.P.3
Striessnig, J.4
-
2
-
-
55749094173
-
Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models
-
Striessnig, J. & Koschak, A. Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin) 2, 233-251 (2008)
-
(2008)
Channels (Austin
, vol.2
, pp. 233-251
-
-
Striessnig, J.1
Koschak, A.2
-
3
-
-
84893867129
-
-
Wiley Interdiscip. Rev. Membr. Transp. Signal
-
Striessnig, J., Pinggera, A., Kaur, G., Bock, G. & Tuluc, P. L-type calcium channels in heart and brain. Wiley Interdiscip. Rev. Membr. Transp. Signal. 3, 15-38 (2014)
-
(2014)
L-type Calcium Channels in Heart and Brain
, vol.3
, pp. 15-38
-
-
Striessnig, J.1
Pinggera, A.2
Kaur, G.3
Bock, G.4
Tuluc, P.5
-
4
-
-
84891509120
-
L-type Cav1.2 calcium channels: From in vitro findings to in vivo function
-
Hofmann, F., Flockerzi, V., Kahl, S. & Wegener, J. W. L-type Cav1.2 calcium channels: from in vitro findings to in vivo function. Physiol. Rev. 94, 303-326 (2014)
-
(2014)
Physiol. Rev
, vol.94
, pp. 303-326
-
-
Hofmann, F.1
Flockerzi, V.2
Kahl, S.3
Wegener, J.W.4
-
5
-
-
0032033732
-
2+ channels
-
DOI 10.1016/S0165-6147(98)01171-7
-
Striessnig, J. et al. Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol. Sci. 19, 108-115 (1998) (Pubitemid 28197812)
-
(1998)
Trends in Pharmacological Sciences
, vol.19
, Issue.3
, pp. 108-115
-
-
Striessnig, J.1
Grabner, M.2
Mitterdorfer, J.3
Hering, S.4
Sinnegger, M.J.5
Glossmann, H.6
-
6
-
-
13944262462
-
2+ channels is dependent on a shank-binding domain
-
DOI 10.1523/JNEUROSCI.3327-04.2005
-
Olson, P. A. et al. G-protein-coupled receptor modulation of striatal Cav1.3 L-type calcium channels is dependent on a Shank-binding domain. J. Neurosci. 25, 1050-1062 (2005) (Pubitemid 40268947)
-
(2005)
Journal of Neuroscience
, vol.25
, Issue.5
, pp. 1050-1062
-
-
Olson, P.A.1
Tkatch, T.2
Hernandez-Lopez, S.3
Ulrich, S.4
Ilijic, E.5
Mugnaini, E.6
Zhang, H.7
Bezprozvanny, I.8
Surmeier, D.J.9
-
7
-
-
69949090356
-
Impaired long-term potentiation and enhanced neuronal excitability in the amygdala of Cav1.3 knockout mice
-
McKinney, B. C., Sze, W., Lee, B. & Murphy, G. G. Impaired long-term potentiation and enhanced neuronal excitability in the amygdala of Cav1.3 knockout mice. Neurobiol. Learn. Mem. 92, 519-528 (2009)
-
(2009)
Neurobiol. Learn. Mem
, vol.92
, pp. 519-528
-
-
Mc Kinney, B.C.1
Sze, W.2
Lee, B.3
Murphy, G.G.4
-
8
-
-
85047691616
-
2+ channels
-
DOI 10.1172/JCI200420208
-
Sinnegger-Brauns, M. J. et al. Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type calcium channels. J. Clin. Invest. 113, 1430-1439 (2004) (Pubitemid 39071698)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.10
, pp. 1430-1439
-
-
Sinnegger-Brauns, M.J.1
Hetzenauer, A.2
Huber, I.G.3
Renstrom, E.4
Wietzorrek, G.5
Berjukov, S.6
Cavalli, M.7
Walter, D.8
Koschak, A.9
Waldschutz, R.10
Hering, S.11
Bova, S.12
Rorsman, P.13
Pongs, O.14
Singewald, N.15
Striessnig, J.16
-
9
-
-
82755176846
-
Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels
-
Bock, G. et al. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J. Biol. Chem. 286, 42736-42748 (2011)
-
(2011)
J. Biol. Chem
, vol.286
, pp. 42736-42748
-
-
Bock, G.1
-
10
-
-
74949101892
-
Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells
-
Marcantoni, A. et al. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J. Neurosci. 30, 491-504 (2010)
-
(2010)
J. Neurosci
, vol.30
, pp. 491-504
-
-
Marcantoni, A.1
-
11
-
-
71849099262
-
Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons
-
Putzier, I., Kullmann, P. H., Horn, J. P. & Levitan, E. S. Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J. Neurosci. 29, 15414-15419 (2009)
-
(2009)
J. Neurosci
, vol.29
, pp. 15414-15419
-
-
Putzier, I.1
Kullmann, P.H.2
Horn, J.P.3
Levitan, E.S.4
-
12
-
-
69749095203
-
Robust pacemaking in substantia nigra dopaminergic neurons
-
Guzman, J. N., Sanchez-Padilla, J., Chan, C. S. & Surmeier, D. J. Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 29, 11011-11019 (2009)
-
(2009)
J. Neurosci
, vol.29
, pp. 11011-11019
-
-
Guzman, J.N.1
Sanchez-Padilla, J.2
Chan, C.S.3
Surmeier, D.J.4
-
13
-
-
79952406815
-
The origins of oxidant stress in parkinson?s disease and therapeutic strategies
-
Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J. & Goldberg, J. A. The origins of oxidant stress in Parkinson?s disease and therapeutic strategies. Antioxid. Redox. Signal. 14, 1289-1301 (2011)
-
(2011)
Antioxid. Redox. Signal
, vol.14
, pp. 1289-1301
-
-
Surmeier, D.J.1
Guzman, J.N.2
Sanchez-Padilla, J.3
Goldberg, J.A.4
-
14
-
-
79958204001
-
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson?s disease
-
Ilijic, E., Guzman, J. N. & Surmeier, D. J. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson?s disease. Neurobiol. Dis. 43, 364-371 (2011)
-
(2011)
Neurobiol. Dis
, vol.43
, pp. 364-371
-
-
Ilijic, E.1
Guzman, J.N.2
Surmeier, D.J.3
-
15
-
-
42049114453
-
Use of antihypertensives and the risk of Parkinson disease
-
DOI 10.1212/01.wnl.0000303818.38960.44, PII 0000611420080415100012
-
Becker, C., Jick, S. S. & Meier, C. R. Use of antihypertensives and the risk of Parkinson disease. Neurology 70, 1438-1444 (2008) (Pubitemid 351521937)
-
(2008)
Neurology
, vol.70
, Issue.16 PART 2
, pp. 1438-1444
-
-
Becker, C.1
Jick, S.S.2
Meier, C.R.3
-
16
-
-
77951735527
-
L-type calcium channel blockers and parkinson disease in denmark
-
Ritz, B. et al. L-type calcium channel blockers and Parkinson disease in Denmark. Ann. Neurol. 67, 600-606 (2010)
-
(2010)
Ann. Neurol
, vol.67
, pp. 600-606
-
-
Ritz, B.1
-
17
-
-
84869409550
-
Cav1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson?s disease
-
Kang, S. et al. Cav1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson?s disease. Nat. Commun. 3, 1146 (2012)
-
(2012)
Nat. Commun
, vol.3
, pp. 1146
-
-
Kang, S.1
-
18
-
-
0035933830
-
A1D (Cav1.3) subunits can form L-type calcium channels activating at negative voltages
-
Koschak, A. et al. a1D (Cav1.3) subunits can form L-type calcium channels activating at negative voltages. J. Biol. Chem. 276, 22100-22106 (2001)
-
(2001)
J. Biol. Chem
, vol.276
, pp. 22100-22106
-
-
Koschak, A.1
-
19
-
-
0035882358
-
1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines
-
Xu, W. & Lipscombe, D. Neuronal Cav1.3a1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J. Neurosci. 21, 5944-5951 (2001) (Pubitemid 32737727)
-
(2001)
Journal of Neuroscience
, vol.21
, Issue.16
, pp. 5944-5951
-
-
Xu, W.1
Lipscombe, D.2
-
20
-
-
34347359673
-
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
-
DOI 10.1038/nature05865, PII NATURE05865
-
Chan, C. S. et al. ?Rejuvenation? protects neurons in mouse models of Parkinson?s disease. Nature 447, 1081-1086 (2007) (Pubitemid 47014425)
-
(2007)
Nature
, vol.447
, Issue.7148
, pp. 1081-1086
-
-
Chan, C.S.1
Guzman, J.N.2
Ilijic, E.3
Mercer, J.N.4
Rick, C.5
Tkatch, T.6
Meredith, G.E.7
Surmeier, D.J.8
-
21
-
-
84879049515
-
Structure-activity relationship of N,N?-disubstituted pyrimidinetriones as cav1.3 calcium channel-selective antagonists for parkinson?s disease
-
Kang, S. et al. Structure-activity relationship of N,N?-disubstituted pyrimidinetriones as Cav1.3 calcium channel-selective antagonists for Parkinson?s disease. J. Med. Chem. 56, 4786-4797 (2013)
-
(2013)
J. Med. Chem
, vol.56
, pp. 4786-4797
-
-
Kang, S.1
-
22
-
-
39149102805
-
V channels
-
DOI 10.1038/nature06529, PII NATURE06529
-
Dick, I. E. et al. A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of Cav channels. Nature 451, 830-834 (2008) (Pubitemid 351253161)
-
(2008)
Nature
, vol.451
, Issue.7180
, pp. 830-834
-
-
Dick, I.E.1
Tadross, M.R.2
Liang, H.3
Tay, L.H.4
Yang, W.5
Yue, D.T.6
-
23
-
-
11244328061
-
V1.2 L-type calcium channels: Dissociation of effects on ionic current and gating current
-
DOI 10.1529/biophysj.104.051714
-
McDonough, S. I., Mori, Y. & Bean, B. P. FPL 64176 modification of Cav1.2 L-type calcium channels: dissociation of effects on ionic current and gating current. Biophys. J. 88, 211-223 (2005) (Pubitemid 40070670)
-
(2005)
Biophysical Journal
, vol.88
, Issue.1
, pp. 211-223
-
-
McDonough, S.I.1
Mori, Y.2
Bean, B.P.3
-
24
-
-
0034066687
-
2+ channels in cardiac myocytes
-
DOI 10.1007/s002100000219
-
Fan, J. S., Yuan, Y. & Palade, P. Kinetic effects of FPL 64176 on L-type Ca2+ channels in cardiac myocytes. Naunyn. Schmiedebergs. Arch. Pharmacol. 361, 465-476 (2000) (Pubitemid 30262594)
-
(2000)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.361
, Issue.5
, pp. 465-476
-
-
Fan, J.-S.1
Yuan, Y.2
Palade, P.3
-
25
-
-
84869032631
-
Cav1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells
-
Vandael, D. H., Zuccotti, A., Striessnig, J. & Carbone, E. Cav1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells. J. Neurosci. 32, 16345-16359 (2012)
-
(2012)
J. Neurosci
, vol.32
, pp. 16345-16359
-
-
Vandael, D.H.1
Zuccotti, A.2
Striessnig, J.3
Carbone, E.4
-
26
-
-
80054823033
-
Are Cav1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage
-
Mahapatra, S., Marcantoni, A., Vandael, D. H., Striessnig, J. & Carbone, E. Are Cav1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels. (Austin) 5, 219-224 (2011)
-
(2011)
Channels. (Austin)
, vol.5
, pp. 219-224
-
-
Mahapatra, S.1
Marcantoni, A.2
Vandael, D.H.3
Striessnig, J.4
Carbone, E.5
-
27
-
-
84879026017
-
Antagonism of l-type ca2+ channels cav1.3 and cav1.2 by 1,4-dihydropyrimidines and 4h-pyrans as dihydropyridine mimics
-
Kang, S. et al. Antagonism of L-type Ca2+ channels Cav1.3 and Cav1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics. Bioorg. Med. Chem. 21, 4365-4373 (2013).
-
(2013)
Bioorg. Med. Chem
, vol.21
, pp. 4365-4373
-
-
Kang, S.1
-
28
-
-
0027449063
-
2+-channel blocker
-
DOI 10.1073/pnas.90.20.9523
-
Glossmann, H. et al. A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca2+-channel blocker. Proc. Natl Acad. Sci. USA 90, 9523-9527 (1993) (Pubitemid 23315817)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.20
, pp. 9523-9527
-
-
Glossmann, H.1
Hering, S.2
Savchenko, A.3
Berger, W.4
Friedrich, K.5
Garcia, M.L.6
Goetz, M.A.7
Liesch, J.M.8
Zink, D.L.9
Kaczorowski, G.J.10
-
29
-
-
33750931290
-
Switching of calcium-dependent inactivation of Cav1.3 channels by calcium binding proteins of auditory hair cells
-
Yang, P. S. et al. Switching of calcium-dependent inactivation of Cav1.3 channels by calcium binding proteins of auditory hair cells. J. Neurosci. 26, 10677-10689 (2006)
-
(2006)
J. Neurosci
, vol.26
, pp. 10677-10689
-
-
Yang, P.S.1
-
30
-
-
33748098546
-
V1.2 channel by its proteolytically processed distal C-terminal domain
-
DOI 10.1113/jphysiol.2006.111799
-
Hulme, J. T., Yarov-Yarovoy, V., Lin, T. W., Scheuer, T. & Catterall, W. A. Autoinhibitory control of the Cav1.2 channel by its proteolytically processed distal C-terminal domain. J. Physiol. 576, 87-102 (2006) (Pubitemid 44426223)
-
(2006)
Journal of Physiology
, vol.576
, Issue.1
, pp. 87-102
-
-
Hulme, J.T.1
Yarov-Yarovoy, V.2
Lin, T.W.-C.3
Scheuer, T.4
Catterall, W.A.5
-
31
-
-
33750433556
-
V1.2 Encodes a Transcription Factor
-
DOI 10.1016/j.cell.2006.10.017, PII S0092867406013432
-
Gomez-Ospina, N., Tsuruta, F., Barreto-Chang, O., Hu, L. & Dolmetsch, R. The C terminus of the L-type voltage-gated calcium channel Cav1.2 encodes a transcription factor. Cell 127, 591-606 (2006) (Pubitemid 44647432)
-
(2006)
Cell
, vol.127
, Issue.3
, pp. 591-606
-
-
Gomez-Ospina, N.1
Tsuruta, F.2
Barreto-Chang, O.3
Hu, L.4
Dolmetsch, R.5
-
32
-
-
0037492580
-
The calcium channel ligand FPL 64176 enhances L-type but inhibits N-type neuronal calcium currents
-
DOI 10.1016/S0028-3908(03)00153-9
-
Liu, L., Gonzalez, P. K., Barrett, C. F. & Rittenhouse, A. R. The calcium channel ligand FPL 64176 enhances L-type but inhibits N-type neuronal calcium currents. Neuropharmacology 45, 281-292 (2003) (Pubitemid 36782541)
-
(2003)
Neuropharmacology
, vol.45
, Issue.2
, pp. 281-292
-
-
Liu, L.1
Gonzalez, P.K.2
Barrett, C.F.3
Rittenhouse, A.R.4
-
33
-
-
84860015582
-
Ca2+ channel activators reveal differential L-type Ca2+ channel pharmacology between native and stem cell-derived cardiomyocytes
-
Kang, J., Chen, X. L., Ji, J., Lei, Q. & Rampe, D. Ca2+ channel activators reveal differential L-type Ca2+ channel pharmacology between native and stem cell-derived cardiomyocytes. J. Pharmacol. Exp. Ther. 341, 510-517 (2012)
-
(2012)
J. Pharmacol. Exp. Ther
, vol.341
, pp. 510-517
-
-
Kang, J.1
Chen, X.L.2
Ji, J.3
Lei, Q.4
Rampe, D.5
-
34
-
-
0035124892
-
V1.3) voltage-dependent calcium currents
-
Bell, D. C. et al. Biophysical properties, pharmacology, and modulation of human, neuronal L-type alpha1D (Cav1.3) voltage-dependent calcium currents. J. Neurophysiol. 85, 816-827 (2001) (Pubitemid 32147782)
-
(2001)
Journal of Neurophysiology
, vol.85
, Issue.2
, pp. 816-827
-
-
Bell, D.C.1
Butcher, A.J.2
Berrow, N.S.3
Page, K.M.4
Brust, P.F.5
Nesterova, A.6
Stauderman, K.A.7
Seabrook, G.R.8
Nurnberg, B.9
Dolphin, A.C.10
-
35
-
-
77954510735
-
The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia
-
Green, E. K. et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 15, 1016-1022 (2010)
-
(2010)
Mol. Psychiatry
, vol.15
, pp. 1016-1022
-
-
Green, E.K.1
-
36
-
-
84864399958
-
Structural determinants of Cav1.3 L-type calcium channel gating
-
Lieb, A., Scharinger, A., Sartori, S., Sinnegger-Brauns, M. J. & Striessnig, J. Structural determinants of Cav1.3 L-type calcium channel gating. Channels (Austin) 6, 197-205 (2012)
-
(2012)
Channels (Austin)
, vol.6
, pp. 197-205
-
-
Lieb, A.1
Scharinger, A.2
Sartori, S.3
Sinnegger-Brauns, M.J.4
Striessnig, J.5
-
37
-
-
17044424577
-
Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of Cav1.1 channels in skeletal muscle
-
Hulme, J. T. et al. Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of Cav1.1 channels in skeletal muscle. Proc. Natl Acad. Sci. USA 102, 5274-5279 (2005)
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, pp. 5274-5279
-
-
Hulme, J.T.1
-
38
-
-
33750804385
-
v1.2 channels during β1-adrenergic regulation
-
DOI 10.1073/pnas.0607294103
-
Hulme, J. T., Westenbroek, R. E., Scheuer, T. & Catterall, W. A. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac Cav1.2 channels during beta1-adrenergic regulation. Proc. Natl Acad. Sci. USA 103, 16574-16579 (2006) (Pubitemid 44715237)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.44
, pp. 16574-16579
-
-
Hulme, J.T.1
Westenforoek, R.E.2
Scheuer, T.3
Catterall, W.A.4
-
39
-
-
77951295326
-
Antagonism of 4-substituted 14-dihydropyridine-35-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca v 1.3 and Ca v 1.2
-
Chang, C. C. et al. Antagonism of 4-substituted 1,4-dihydropyridine-3,5- dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2. Bioorg. Med. Chem. 18, 3147-3158 (2010).
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 3147-3158
-
-
Chang, C.C.1
|